Comparison between Mono Pharmacare IPO and Pramara Promotions IPO.
IPO Details
Mono Pharmacare IPO is a SME Fixed Price IPO proposed to list at NSE SME while Pramara Promotions IPO is a SME Fixed Price proposed to list at NSE SME.
Issue Size and Price
The total issue size of Mono Pharmacare IPO is up to ₹14.07 Cr whereas the issue size of the Pramara Promotions IPO is up to ₹14.49 Cr. The final issue price of Mono Pharmacare IPO is ₹28.00 per share and of Pramara Promotions IPO is ₹63.00 per share.
IPO Timetable
Mono Pharmacare IPO opens on Aug 28, 2023, while Pramara Promotions IPO opens on Sep 01, 2023. The closing date of Mono Pharmacare IPO and Pramara Promotions IPO is Aug 30, 2023, and Sep 05, 2023, respectively.
| | Mono Pharmacare IPO | Pramara Promotions IPO |
|---|
| Issue Open | Aug 28, 2023 | Sep 01, 2023 |
| Issue Close | Aug 30, 2023 | Sep 05, 2023 |
| Basis Of Allotment (Tentative) | Sep 04, 2023 | Sep 08, 2023 |
| Initiation of Refunds (Tentative) | Sep 05, 2023 | Sep 11, 2023 |
| Credit of Share (Tentative) | Sep 06, 2023 | Sep 12, 2023 |
| Listing date (Tentative) | Sep 07, 2023 | Sep 13, 2023 |
Financials & KPIs
Mono Pharmacare IPO P/E ratio is , as compared to Pramara Promotions IPO P/E ratio of .
Shares Offered
In the Mono Pharmacare IPO Retail Individual Investors (RII) are offered 22,64,000 shares while in Pramara Promotions IPO retail investors are offered 22,64,000 shares. Qualified Institutional Buyers (QIB) are offered 5,00,000 shares in Mono Pharmacare IPO and in Pramara Promotions IPO.
| | Mono Pharmacare IPO | Pramara Promotions IPO |
|---|
| Market Maker Reservation | 2,76,000 shares | 1,24,000 shares |
| QIB | 5,00,000 shares | |
| NII | 22,60,000 shares | 11,50,000 shares |
| RII | 22,64,000 shares | 11,50,000 shares |
| Total | 50,24,000 shares | 23,00,000 shares |
Bids Received (Subscription)
Mono Pharmacare IPO subscribed 13.42x in total, whereas Pramara Promotions IPO subscribed 25.56x.
